产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 57-71-6 |
|---|---|---|---|
| 分子式 | C25H52NO4P | 纯度 | >99% |
| 分子量 | 461.66 | 货号 | abs47027927 |
| 规格 | 25mg | 供货周期 | 现货 |
| 主要用途 | is an inhibitor of skeletal | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
2,3-Butanedione 2-Monoxime 57-71-6
| 产品描述 | |
| 描述 | 2,3-Butanedione 2-Monoxime is an inhibitor of skeletal and cardiac muscle contraction. |
| 纯度 | >99% |
| 储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 别名 | 2,3-丁烷二酮一肟;二乙酰一肟;NSC 660;NSC 116103 |
| 外观 | 白色至类白色结晶性粉末 |
| 可溶性/溶解性 | 10 mM in DMSO |
| 生物活性 | |
| 靶点 | skeletal muscle myosin-II |
| In vitro(体外研究) | BDM inhibits skeletal muscle myosin-II, but it does not inhibit the ATPase activity of the other myosins. BDM has a broad effect on many non-myosin proteins (many uncharacterized), and thus should not be used in whole-cell experiments as a myosin inhibitor. BDM inhibits the L-type Ca2+-channel and reduces the opening probability, thereby increasing the closed time of this particular channel. BDM drives nonspecific protein dephosphorylation of many cellular proteins, including ion channels. |
| In vivo(体内研究) | BDM significant lowers the blood pressure in normo- and hypertensive rats. BDM has been shown to improve right atrial function in a porcine model of allogenic heart transplantation. |
| 参考文献 | |
| 参考文献 |
|
| 研究领域 | |
| 研究领域 | Metabolism Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询